首页> 美国卫生研究院文献>Iranian Journal of Pharmaceutical Research : IJPR >Comprehensive Evaluation of Gene Expression in Negative and Positive Trigger-based Targeting Niosomes in HEK-293 Cell Line
【2h】

Comprehensive Evaluation of Gene Expression in Negative and Positive Trigger-based Targeting Niosomes in HEK-293 Cell Line

机译:HEK-293细胞系中阴性触发靶性靶位性基因表达综合评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An efficient gene delivery system has some critical factors that enhance the efficiency of nanocarrier. These factors are low production cost, high bioavailability, high encapsulation efficiency, controllable release, and targeting ability. Niosome (the nonionic surfactant vesicles) was considered as a promising gene delivery system. Niosome can increase stability and uptake of active agents. We used all mentioned factors in one optimized formulation entitled plasmid- loaded magnetic niosomes (PMN). To increase the bioavailability of niosomes, we used ergosterol (a natural lipid) instead of cholesterol in structure of niosome. Also, cetyl trimethyl ammonium bromide (CTAB) in different concentrations was used to improve encapsulation of plasmid and compared to niosomes that did not have CTAB (negative niosome). Afterward, magnetic nanoparticle (Fe O @SiO ) was synthesized and loaded into niosome to obtain targeting ability. Prepared formulations were evaluated regarding size, zeta potential, morphology, encapsulation of magnetic nanoparticles and plasmid (Pm-cherry-N1), release rate, and transfection efficiency. Results demonstrated that optimum formulation (Nio/CTAB3%/Fe/P) has a nanometric size (118 ± 2.31 nm, positive zeta potential (+25 ± 0.67 mV), high loading of plasmid (72%), and good gene expression (35%). Interestingly, after applying a magnetic field below the cell plate, we obtained ac increased gene expression from 35% to 42%. These results showed that this new formulation would have a promising future and also can be used for delivering the other drugs and active agents.
机译:有效的基因递送系统具有提高纳米载波效率的一些关键因素。这些因素是生产成本低,生物利用度高,封装效率高,可控释放和靶向能力。定期(非离子表面活性剂囊泡)被认为是有前途的基因递送系统。定位数可以增加活性剂的稳定性和吸收。我们在一个优化的配方中使用了所有提到的因素,标题有题为质粒磁性Niosomes(PMN)。为了提高憩室的生物利用度,我们使用ergosterol(一种天然脂质)而不是胆固醇在定期组织结构中。此外,使用不同浓度的三甲醚三甲基溴化铵(CTAB)来改善质粒的包封,并与没有CTAB(阴性定位数)的憩室相比。之后,合成磁性纳米粒子(Fe O o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o评估制备的制剂关于尺寸,Zeta电位,形态,磁性纳米粒子和质粒(PM-Cherry-N1)的包封,释放率和转染效率。结果表明,最佳配方(NIO / CTAB3%/ Fe / P)具有纳米尺寸(118±2.31nm,阳性Zeta电位(+ 25±0.67mV),高负荷的质粒(72%)和良好的基因表达( 35%)。有趣的是,在将磁场施加在细胞板下方之后,获得AC增加的基因表达从35%到42%。这些结果表明,这种新的配方将具有有希望的未来,也可以用于提供另一个未来药物和活性剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号